Open access
149
Views
1
CrossRef citations to date
0
Altmetric
REVIEW
Quantifying the Value of Introducing an Oral Drug Delivery Option for Edaravone: A Review of Analyses Evaluating the Economic Impact of Oral versus Intravenous Formulations
Naoko A Ronquest1 Health Economics, RTI Health Solutions, Research Triangle Park, Durham, NC, USACorrespondence[email protected]
https://orcid.org/0000-0002-0496-9973View further author information
, https://orcid.org/0000-0002-0496-9973View further author information
Kyle Paret1 Health Economics, RTI Health Solutions, Research Triangle Park, Durham, NC, USAhttps://orcid.org/0000-0002-0589-2031View further author information
, Aaron Lucas1 Health Economics, RTI Health Solutions, Research Triangle Park, Durham, NC, USAView further author information
, Malgorzata Ciepielewska2 Medical Affairs-HEOR/RWE/Publications, Mitsubishi Tanabe Pharma America, Inc, Jersey City, NJ, USAView further author information
& Melissa Hagan2 Medical Affairs-HEOR/RWE/Publications, Mitsubishi Tanabe Pharma America, Inc, Jersey City, NJ, USAView further author information
Pages 499-511
|
Received 12 Feb 2022, Accepted 28 Jun 2022, Published online: 27 Jul 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.